Biogen (NASDAQ:BIIB) exceeded Wall Street forecasts with its Q2 2023 results on Tuesday and announced a new cost savings program including plans to reduce about 1,000 employees as the company shifts its resources to newly approved medications.
https://seekingalpha.com/news/3990514-biogen-announces-layoffs-as-focus-turns-to-new-products